-
1
-
-
0031934907
-
Olecranon bursitis caused by infection with Candida lusitaniae
-
Behar S.M., and Chertow G.M. Olecranon bursitis caused by infection with Candida lusitaniae. J. Rheumatol. 25 (1998) 598-600
-
(1998)
J. Rheumatol.
, vol.25
, pp. 598-600
-
-
Behar, S.M.1
Chertow, G.M.2
-
4
-
-
0141764430
-
Candida
-
Anaissie E.J., McGinnis M.R., and Pfaller M.A. (Eds), Elsevier, Philadelphia
-
Dignani M.C., Solomkin J.S., and Anaissie E.J. Candida. In: Anaissie E.J., McGinnis M.R., and Pfaller M.A. (Eds). Clinical mycology (2003), Elsevier, Philadelphia 195-239
-
(2003)
Clinical mycology
, pp. 195-239
-
-
Dignani, M.C.1
Solomkin, J.S.2
Anaissie, E.J.3
-
5
-
-
33644645239
-
Candida species
-
Mandell G.L., Bennett J.E., and Dolin R. (Eds), Elsevier, Philadelphia
-
Edwards J.E. Candida species. In: Mandell G.L., Bennett J.E., and Dolin R. (Eds). Principles and Practice of Infectious Diseases (2005), Elsevier, Philadelphia 2938-2957
-
(2005)
Principles and Practice of Infectious Diseases
, pp. 2938-2957
-
-
Edwards, J.E.1
-
6
-
-
1642314633
-
Susceptibility of clinical isolates of Candida lusitaniae to five systemic antifungal agents
-
Favel A., Michel-Nguyen A., Datry A., Challier S., Leclerc F., Chastain C., Fallague K., and Regli P. Susceptibility of clinical isolates of Candida lusitaniae to five systemic antifungal agents. J. Antimicrob. Chemother. 53 (2004) 526-529
-
(2004)
J. Antimicrob. Chemother.
, vol.53
, pp. 526-529
-
-
Favel, A.1
Michel-Nguyen, A.2
Datry, A.3
Challier, S.4
Leclerc, F.5
Chastain, C.6
Fallague, K.7
Regli, P.8
-
7
-
-
34547880009
-
Candida lusitaniae arthritis in an intravenous drug user
-
Jeragh A., Ahmad S., Naseem J., and Khun Z.U. Candida lusitaniae arthritis in an intravenous drug user. Mycoses 50 (2007) 430-432
-
(2007)
Mycoses
, vol.50
, pp. 430-432
-
-
Jeragh, A.1
Ahmad, S.2
Naseem, J.3
Khun, Z.U.4
-
8
-
-
0021677879
-
Candida lusitaniae: frequency of recovery, colonization, infection and amphotericin B resistance
-
Merz W.G. Candida lusitaniae: frequency of recovery, colonization, infection and amphotericin B resistance. J. Clin. Microbiol. 20 (1984) 1194-1195
-
(1984)
J. Clin. Microbiol.
, vol.20
, pp. 1194-1195
-
-
Merz, W.G.1
-
9
-
-
0035245285
-
Candida lusitaniae: a cause of breakthrough fungemia in cancer patients
-
Minari A., Hachem R., and Raad I. Candida lusitaniae: a cause of breakthrough fungemia in cancer patients. Clin. Infect. Dis. 32 (2001) 186-190
-
(2001)
Clin. Infect. Dis.
, vol.32
, pp. 186-190
-
-
Minari, A.1
Hachem, R.2
Raad, I.3
-
12
-
-
0742299199
-
Guidelines for treatment of candidiasis
-
Infectious Disease Society of America
-
Pappas P.G., Rex J.H., Sobel J.D., Filler S.G., Dismukes W.E., Walsh T.J., Edwards J.E., and Infectious Disease Society of America. Guidelines for treatment of candidiasis. Clin. Infect. Dis. 38 (2004) 161-189
-
(2004)
Clin. Infect. Dis.
, vol.38
, pp. 161-189
-
-
Pappas, P.G.1
Rex, J.H.2
Sobel, J.D.3
Filler, S.G.4
Dismukes, W.E.5
Walsh, T.J.6
Edwards, J.E.7
-
13
-
-
0031968985
-
Role of the new azoles in the treatment of fungal osteoarticular infections
-
Perez-Gomez A., Prieto A., Torresano M., Diez E., Mulero J., Labiano I., and Andreu J.L. Role of the new azoles in the treatment of fungal osteoarticular infections. Semin. Arthritis. Rheum. 27 (1998) 226-244
-
(1998)
Semin. Arthritis. Rheum.
, vol.27
, pp. 226-244
-
-
Perez-Gomez, A.1
Prieto, A.2
Torresano, M.3
Diez, E.4
Mulero, J.5
Labiano, I.6
Andreu, J.L.7
-
14
-
-
12244253033
-
In vitro activities of voriconazole, posaconazole, and four licensed systemic antifungal agents against Candida species infrequently isolated from blood
-
and the International Fungal Surveillance Participant Group
-
Pfaller M.A., Diekema D.J., Messer S.A., Boyken L., Hollis R.J., Jones R.N., and and the International Fungal Surveillance Participant Group. In vitro activities of voriconazole, posaconazole, and four licensed systemic antifungal agents against Candida species infrequently isolated from blood. J. Clin. Microbiol. 41 (2003) 78-83
-
(2003)
J. Clin. Microbiol.
, vol.41
, pp. 78-83
-
-
Pfaller, M.A.1
Diekema, D.J.2
Messer, S.A.3
Boyken, L.4
Hollis, R.J.5
Jones, R.N.6
-
15
-
-
0027263997
-
Candida arthritis
-
Silveira L.H., Cuellar M.L., Citera G., Cabrera G.E., Scopelitis E., and Espinoza L.R. Candida arthritis. Rheum. Dis. Clin. North Am. 19 (1993) 427-437
-
(1993)
Rheum. Dis. Clin. North Am.
, vol.19
, pp. 427-437
-
-
Silveira, L.H.1
Cuellar, M.L.2
Citera, G.3
Cabrera, G.E.4
Scopelitis, E.5
Espinoza, L.R.6
-
16
-
-
0036250180
-
Two cases of fungemia due to Candida lusitaniae and a literature review
-
Viudes A., Peman J., Canton E., Salavert M., Ubeda P., Lopez-Ribot J.L., and Gobernado M. Two cases of fungemia due to Candida lusitaniae and a literature review. Eur. J. Clin. Microbiol. Infect. Dis. 21 (2002) 294-299
-
(2002)
Eur. J. Clin. Microbiol. Infect. Dis.
, vol.21
, pp. 294-299
-
-
Viudes, A.1
Peman, J.2
Canton, E.3
Salavert, M.4
Ubeda, P.5
Lopez-Ribot, J.L.6
Gobernado, M.7
-
17
-
-
0032892997
-
High-frequency, in vitro reversible switching of Candida lusitaniae clinical isolates from amphotericin B susceptibility to resistance
-
Yoon S.A., Vazquez J.A., Steffan P.E., Sobel J.D., and Akins R.A. High-frequency, in vitro reversible switching of Candida lusitaniae clinical isolates from amphotericin B susceptibility to resistance. Antimicrob. Agents Chemother. 43 (1999) 836-845
-
(1999)
Antimicrob. Agents Chemother.
, vol.43
, pp. 836-845
-
-
Yoon, S.A.1
Vazquez, J.A.2
Steffan, P.E.3
Sobel, J.D.4
Akins, R.A.5
-
18
-
-
0032836361
-
Candida glabrata arthritis: case report and review of the literature of candida arthritis
-
Zmierczak H., Goemaere S., Mielants H., Verbruggen G., and Veys E.M. Candida glabrata arthritis: case report and review of the literature of candida arthritis. Clin. Rheumatol. 18 (1999) 406-409
-
(1999)
Clin. Rheumatol.
, vol.18
, pp. 406-409
-
-
Zmierczak, H.1
Goemaere, S.2
Mielants, H.3
Verbruggen, G.4
Veys, E.M.5
|